المؤلفون: Morschhauser, F, Dahiya, S, Palomba, ML, Martin Garcia-Sancho, A, Reguera Ortega, JL, Kuruvilla, J, Jäger, U, Cartron, G, Izutsu, K, Dreyling, M, Kahl, B, Ghesquieres, H, Ardeshna, K, Goto, H, Barbui, AM, Abramson, JS, Borchmann, P, Fleury, I, Mielke, S, Skarbnik, A, de Vos, S, Kamdar, M, Karmali, R, Viardot, A, Farazi, T, Fasan, O, Lymp, J, Vedal, M, Nishii, R, Avilion, A, Papuga, J, Kumar, J, Nastoupil, LJ

المصدر: Nature medicine.

مصطلحات موضوعية: Medicin och hälsovetenskap

URL الوصول: http://kipublications.ki.se/Default.aspx?queryparsed=id:238982297

المؤلفون: Morschhauser F; Centre Hospitalier Universitaire de Lille, Groupe de Recherche sur les formes Injectables et les Technologies Associées, Lille, France. franck.morschhauser@chu-lille.fr., Dahiya S; Stanford University School of Medicine, Stanford, CA, USA.; University of Maryland Greenebaum Comprehensive Cancer Center, Baltimore, MD, USA., Palomba ML; Memorial Sloan Kettering Cancer Center, New York, NY, USA., Martin Garcia-Sancho A; Hospital Universitario de Salamanca, IBSAL, CIBERONC, Centro de Investigación del Cáncer-IBMCC (USAL-CSIC), Salamanca, Spain., Reguera Ortega JL; Hospital Virgen del Rocío, Instituto de Biomedicina de la Universidad de Sevilla, Seville, Spain., Kuruvilla J; Princess Margaret Cancer Centre, Toronto, Ontario, Canada., Jäger U; Medical University of Vienna, Vienna, Austria., Cartron G; Montpellier University Hospital Center, UMR CNRS 5535, Montpellier, France., Izutsu K; National Cancer Center Hospital, Tokyo, Japan., Dreyling M; LMU University Hospital, München, Germany., Kahl B; Washington University School of Medicine in St. Louis, St. Louis, MO, USA., Ghesquieres H; Hôpital Lyon Sud, Lyon, France., Ardeshna K; University College London Hospitals Biomedical Research Centre, London, UK., Goto H; Hokkaido University Hospital, Sapporo, Japan., Barbui AM; Azienda Socio Sanitaria Territoriale Papa Giovanni XXIII, Bergamo, Italy., Abramson JS; Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA, USA., Borchmann P; Universität zu Köln, Köln, Germany., Fleury I; Hôpital Maisonneuve - Rosemont, Montreal, Quebec, Canada., Mielke S; Karolinska Institutet and University Hospital, Karolinska Comprehensive Cancer Center, Karolinska ATMP Center, Stockholm, Sweden., Skarbnik A; Novant Health Cancer Institute, Charlotte, NC, USA., de Vos S; UCLA Santa Monica Medical Centre, Santa Monica, CA, USA., Kamdar M; University of Colorado Cancer Center, Aurora, CO, USA., Karmali R; Northwestern University Feinberg School of Medicine, Robert H. Lurie Comprehensive Cancer Center, Chicago, IL, USA., Viardot A; Department of Internal Medicine III, University Hospital, Ulm, Germany., Farazi T; Bristol Myers Squibb, Brisbane, CA, USA., Fasan O; Bristol Myers Squibb, Princeton, NJ, USA., Lymp J; Bristol Myers Squibb, Seattle, WA, USA., Vedal M; Bristol Myers Squibb, Seattle, WA, USA., Nishii R; Bristol Myers Squibb, Princeton, NJ, USA., Avilion A; Bristol Myers Squibb, Seattle, WA, USA., Papuga J; Bristol Myers Squibb, Boudry, Switzerland., Kumar J; Bristol Myers Squibb, Princeton, NJ, USA., Nastoupil LJ; The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

المصدر: Nature medicine [Nat Med] 2024 Aug; Vol. 30 (8), pp. 2199-2207. Date of Electronic Publication: 2024 Jun 03.

نوع المنشور: Journal Article; Clinical Trial, Phase II; Multicenter Study

بيانات الدورية: Publisher: Nature Publishing Company Country of Publication: United States NLM ID: 9502015 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1546-170X (Electronic) Linking ISSN: 10788956 NLM ISO Abbreviation: Nat Med Subsets: MEDLINE

مواضيع طبية MeSH: Lymphoma, Follicular*/therapy , Lymphoma, Follicular*/immunology , Lymphoma, Follicular*/drug therapy , Immunotherapy, Adoptive*/adverse effects , Immunotherapy, Adoptive*/methods, Humans ; Male ; Middle Aged ; Female ; Aged ; Adult ; Antigens, CD19/immunology ; Antigens, CD19/therapeutic use ; Receptors, Chimeric Antigen/immunology ; Receptors, Chimeric Antigen/therapeutic use

المؤلفون: Bailén R; Department of Hematology, Hospital General Universitario Gregorio Marañón, Madrid, Spain.; Gregorio Marañón Health Research Institute, Madrid, Spain., Iacoboni G; Department of Hematology, Vall d'Hebron University Hospital, Experimental Hematology, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.; Department of Medicine, Universitat Autònoma de Barcelona, Bellaterra, Spain., Delgado J; Department of Haematology, Hospital Universitario Virgen del Rocío, Institute of Biomedicine of Seville (IBiS/CSIC/CIBERONC), University of Seville, Seville, Spain., López-Corral L; Department of Hematology, Hospital Clínico Universitario de Salamanca, IBSAL, Salamanca, Spain., Hernani-Morales R; Department of Hematology, Hospital Clínico Universitario de Valencia, Instituto de Investigación Sanitaria INCLIVA, Valencia, Spain., Ortiz-Maldonado V; Department of Haematology, Hospital Clínic, Barcelona, Spain., Guerreiro M; Department of Hematology, Hospital Universitario y Politécnico La Fe, Valencia, Spain., Caballero AC; Department of Hematology, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain., Domínguez MLG; Department of Hematology, Hospital Universitario de Gran Canaria Doctor Negrín, Las Palmas de Gran Canaria, Spain., Sánchez-Pina JM; Department of Hematology, Hospital Universitario 12 de Octubre, Madrid, Spain., Peña M; Department of Hematology, Hospital Duran i Reynals, Instituto Catalán de Oncología, IDIBELL, Barcelona, Spain., Torrent A; Department of Hematology, Hospital Universitari Germans Trias i Pujol, Badalona, Spain., Pérez-Martínez A; Department of Paediatric Hemato-Oncology, Hospital Universitario La Paz, Madrid, Spain., Bastos M; Department of Hematology, Hospital General Universitario Gregorio Marañón, Madrid, Spain.; Gregorio Marañón Health Research Institute, Madrid, Spain.; Universidad Complutense de Madrid, Spain., Reguera-Ortega JL; Department of Haematology, Hospital Universitario Virgen del Rocío, Institute of Biomedicine of Seville (IBiS/CSIC/CIBERONC), University of Seville, Seville, Spain., Martín A; Department of Hematology, Hospital Clínico Universitario de Salamanca, IBSAL, Salamanca, Spain., Hernandez-Boluda JC; Department of Hematology, Hospital Clínico Universitario de Valencia, Instituto de Investigación Sanitaria INCLIVA, Valencia, Spain., Martínez-Cibrián N; Department of Haematology, Hospital Clínic, Barcelona, Spain., Sanz J; Department of Hematology, Hospital Universitario y Politécnico La Fe, Valencia, Spain., Briones J; Department of Hematology, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain., Henriquez HL; Department of Hematology, Hospital Universitario de Gran Canaria Doctor Negrín, Las Palmas de Gran Canaria, Spain., Calbacho M; Department of Hematology, Hospital Universitario 12 de Octubre, Madrid, Spain., Mussetti A; Department of Hematology, Hospital Duran i Reynals, Instituto Catalán de Oncología, IDIBELL, Barcelona, Spain., Sancho JM; Department of Hematology, Hospital Universitari Germans Trias i Pujol, Badalona, Spain., Barba P; Department of Hematology, Vall d'Hebron University Hospital, Experimental Hematology, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.; Department of Medicine, Universitat Autònoma de Barcelona, Bellaterra, Spain., Kwon M; Department of Hematology, Hospital General Universitario Gregorio Marañón, Madrid, Spain.; Gregorio Marañón Health Research Institute, Madrid, Spain.; Universidad Complutense de Madrid, Spain.. Electronic address: mi.kwon@salud.madrid.org.

مؤلفون مشاركون: GETH-TC (Spanish Group of Stem Cell Transplantation and Cell Therapy) and GELTAMO (Spanish Group of Lymphoma and Autologous Stem Cell Transplantation)

المصدر: Transplantation and cellular therapy [Transplant Cell Ther] 2024 Jul 26. Date of Electronic Publication: 2024 Jul 26.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Elsevier Inc Country of Publication: United States NLM ID: 101774629 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2666-6367 (Electronic) Linking ISSN: 26666367 NLM ISO Abbreviation: Transplant Cell Ther Subsets: MEDLINE

المؤلفون: Iacoboni G; Department of Hematology University Hospital Vall d'Hebron Barcelona Spain.; Experimental Hematology, Vall d'Hebron Institute of Oncology (VHIO) Barcelona Spain.; Department of Medicine Universitat Autònoma de Barcelona Bellaterra Spain., Sánchez-Salinas MA; Department of Hematology University Hospital Vall d'Hebron Barcelona Spain.; Experimental Hematology, Vall d'Hebron Institute of Oncology (VHIO) Barcelona Spain.; Department of Medicine Universitat Autònoma de Barcelona Bellaterra Spain., Rejeski K; Department of Medicine III University Hospital, LMU Munich Munich Germany.; Laboratory for Translational Cancer Immunology Gene Center of the LMU Munich Munich Germany.; Adult BMT and Cellular Therapy Service Memorial Sloan Kettering Cancer Center New York New York USA., Martín-López AÁ; Hematology Department Hospital Clínico Universitario de Salamanca, IBSAL, CIBERONC Salamanca Spain.; Centro de Investigación del Cáncer-IBMCC Salamanca Spain., Kwon M; Department of Hematology Hospital General Universitario Gregorio Marañón Madrid Spain.; Gregorio Marañón Health Research Institute (IiSGM) Madrid Spain., Navarro V; Oncology Data Science (ODySey) Group, Vall d'Hebron Institute of Oncology (VHIO) Barcelona Spain., Jalowiec KA; Hematology Department University College London Cancer Institute London United Kingdom.; Department of Hematology and Central Hematology Laboratory University Hospital of Bern Bern Switzerland., Hernani R; Haematology Department Hospital Clínico Universitario Valencia Spain.; INCLIVA Research Institute Valencia Spain., Reguera-Ortega JL; Hematology Department, Hospital Virgen del Rocío, Instituto de Biomedicina de Sevilla (IBIS)/CSIC Universidad de Sevilla Sevilla Spain., Gallur L; Department of Hematology University Hospital Vall d'Hebron Barcelona Spain.; Experimental Hematology, Vall d'Hebron Institute of Oncology (VHIO) Barcelona Spain.; Department of Medicine Universitat Autònoma de Barcelona Bellaterra Spain., Blumenberg V; Department of Medicine III University Hospital, LMU Munich Munich Germany.; Laboratory for Translational Cancer Immunology Gene Center of the LMU Munich Munich Germany., Herrero-García M; Cancer Research Centre (IBMCC, USAL-CSIC), Institute for Biomedical Research of Salamanca (IBSAL) and Department of Medicine and Cytometry Service (NUCLEUS Research Support Platform) University of Salamanca (USAL) Salamanca Spain., Roddie C; Hematology Department University College London Cancer Institute London United Kingdom., Benzaquén A; Haematology Department Hospital Clínico Universitario Valencia Spain.; INCLIVA Research Institute Valencia Spain., Delgado-Serrano J; Hematology Department, Hospital Virgen del Rocío, Instituto de Biomedicina de Sevilla (IBIS)/CSIC Universidad de Sevilla Sevilla Spain., Bailén R; Department of Hematology Hospital General Universitario Gregorio Marañón Madrid Spain.; Gregorio Marañón Health Research Institute (IiSGM) Madrid Spain., Carpio C; Department of Hematology University Hospital Vall d'Hebron Barcelona Spain.; Experimental Hematology, Vall d'Hebron Institute of Oncology (VHIO) Barcelona Spain.; Department of Medicine Universitat Autònoma de Barcelona Bellaterra Spain., Amat P; Haematology Department Hospital Clínico Universitario Valencia Spain.; INCLIVA Research Institute Valencia Spain., López-Corral L; Hematology Department Hospital Clínico Universitario de Salamanca, IBSAL, CIBERONC Salamanca Spain.; Centro de Investigación del Cáncer-IBMCC Salamanca Spain., Martín-Martín L; Cancer Research Centre (IBMCC, USAL-CSIC), Institute for Biomedical Research of Salamanca (IBSAL) and Department of Medicine and Cytometry Service (NUCLEUS Research Support Platform) University of Salamanca (USAL) Salamanca Spain., Bastos M; Department of Hematology Hospital General Universitario Gregorio Marañón Madrid Spain.; Gregorio Marañón Health Research Institute (IiSGM) Madrid Spain., Subklewe M; Department of Medicine III University Hospital, LMU Munich Munich Germany.; Laboratory for Translational Cancer Immunology Gene Center of the LMU Munich Munich Germany., O'Reilly M; Hematology Department University College London Cancer Institute London United Kingdom., Barba P; Department of Hematology University Hospital Vall d'Hebron Barcelona Spain.; Experimental Hematology, Vall d'Hebron Institute of Oncology (VHIO) Barcelona Spain.; Department of Medicine Universitat Autònoma de Barcelona Bellaterra Spain.

المصدر: HemaSphere [Hemasphere] 2024 Jun 26; Vol. 8 (7), pp. e86. Date of Electronic Publication: 2024 Jun 26 (Print Publication: 2024).

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Wiley Country of Publication: United States NLM ID: 101740619 Publication Model: eCollection Cited Medium: Internet ISSN: 2572-9241 (Electronic) Linking ISSN: 25729241 NLM ISO Abbreviation: Hemasphere Subsets: PubMed not MEDLINE

المؤلفون: Iacoboni G; Department of Hematology, University Hospital Vall d'Hebron, Barcelona, Spain.; Experimental Hematology, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.; Department of Medicine, Universitat Autònoma de Barcelona, Bellaterra, Spain., Navarro V; Oncology Data Science (ODySey) Group, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain., Martín-López AÁ; Hematology Department, Hospital Clínico Universitario de Salamanca, IBSAL, CIBERONC, Salamanca, Spain.; Centro de Investigación del Cáncer-IBMCC, Salamanca, Spain., Rejeski K; Department of Medicine III, University Hospital, LMU Munich, Munich, Germany.; Laboratory for Translational Cancer Immunology, Gene Center of the LMU Munich, Munich, Germany.; German Cancer Consortium (DKTK) and Bavarian Center for Cancer Research (BZKF), partner site Munich, Munich, Germany., Kwon M; Department of Hematology, Hospital General Universitario Gregorio Marañón, Madrid, Spain.; Gregorio Marañón Health Research Institute (IiSGM), Madrid, Spain., Jalowiec KA; Hematology Department, University College London Cancer Institute, London, United Kingdom.; Department of Hematology and Central Hematology Laboratory, University Hospital of Bern, Bern, Switzerland., Amat P; Haematology Department, Hospital Clínico Universitario, Valencia, Spain.; INCLIVA Research Institute, Valencia, Spain., Reguera-Ortega JL; Hematology Department, Hospital Virgen del Rocío, Instituto de Biomedicina de Sevilla (IBIS)/CSIC, Universidad de Sevilla, Sevilla, Spain., Gallur L; Department of Hematology, University Hospital Vall d'Hebron, Barcelona, Spain.; Experimental Hematology, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.; Department of Medicine, Universitat Autònoma de Barcelona, Bellaterra, Spain., Blumenberg V; Department of Medicine III, University Hospital, LMU Munich, Munich, Germany.; Laboratory for Translational Cancer Immunology, Gene Center of the LMU Munich, Munich, Germany.; German Cancer Consortium (DKTK) and Bavarian Center for Cancer Research (BZKF), partner site Munich, Munich, Germany., Gutiérrez-Herrero S; Cancer Research Centre (IBMCC, USAL-CSIC), Institute for Biomedical Research of Salamanca (IBSAL) and Department of Medicine and Cytometry Service (NUCLEUS Research Support Platform), University of Salamanca (USAL), Salamanca, Spain., Roddie C; Hematology Department, University College London Cancer Institute, London, United Kingdom., Benzaquén A; Haematology Department, Hospital Clínico Universitario, Valencia, Spain.; INCLIVA Research Institute, Valencia, Spain., Delgado-Serrano J; Hematology Department, Hospital Virgen del Rocío, Instituto de Biomedicina de Sevilla (IBIS)/CSIC, Universidad de Sevilla, Sevilla, Spain., Sánchez-Salinas MA; Department of Hematology, University Hospital Vall d'Hebron, Barcelona, Spain.; Experimental Hematology, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.; Department of Medicine, Universitat Autònoma de Barcelona, Bellaterra, Spain., Bailén R; Department of Hematology, Hospital General Universitario Gregorio Marañón, Madrid, Spain.; Gregorio Marañón Health Research Institute (IiSGM), Madrid, Spain., Carpio C; Department of Hematology, University Hospital Vall d'Hebron, Barcelona, Spain.; Experimental Hematology, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.; Department of Medicine, Universitat Autònoma de Barcelona, Bellaterra, Spain., López-Corral L; Hematology Department, Hospital Clínico Universitario de Salamanca, IBSAL, CIBERONC, Salamanca, Spain.; Centro de Investigación del Cáncer-IBMCC, Salamanca, Spain., Hernani R; Haematology Department, Hospital Clínico Universitario, Valencia, Spain.; INCLIVA Research Institute, Valencia, Spain., Bastos M; Department of Hematology, Hospital General Universitario Gregorio Marañón, Madrid, Spain.; Gregorio Marañón Health Research Institute (IiSGM), Madrid, Spain., O'Reilly M; Hematology Department, University College London Cancer Institute, London, United Kingdom., Martín-Martín L; Cancer Research Centre (IBMCC, USAL-CSIC), Institute for Biomedical Research of Salamanca (IBSAL) and Department of Medicine and Cytometry Service (NUCLEUS Research Support Platform), University of Salamanca (USAL), Salamanca, Spain., Subklewe M; Department of Medicine III, University Hospital, LMU Munich, Munich, Germany.; Laboratory for Translational Cancer Immunology, Gene Center of the LMU Munich, Munich, Germany.; German Cancer Consortium (DKTK) and Bavarian Center for Cancer Research (BZKF), partner site Munich, Munich, Germany., Barba P; Department of Hematology, University Hospital Vall d'Hebron, Barcelona, Spain.; Experimental Hematology, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.; Department of Medicine, Universitat Autònoma de Barcelona, Bellaterra, Spain.

المصدر: Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2024 Jan 10; Vol. 42 (2), pp. 205-217. Date of Electronic Publication: 2023 Oct 24.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 8309333 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1527-7755 (Electronic) Linking ISSN: 0732183X NLM ISO Abbreviation: J Clin Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Receptors, Chimeric Antigen* , Blood Component Removal* , Lymphoma, Large B-Cell, Diffuse*, Humans ; Bendamustine Hydrochloride/adverse effects ; Immunotherapy, Adoptive/adverse effects ; Antigens, CD19 ; Cell- and Tissue-Based Therapy

المؤلفون: Pérez-Moreno MA; Department of Pharmacy, University Hospital Virgen del Rocío, 41013 Seville, Spain., Ciudad-Gutiérrez P; Department of Pharmacy, University Hospital Virgen del Rocío, 41013 Seville, Spain., Jaramillo-Ruiz D; Department of Pharmacy, University Hospital Virgen del Rocío, 41013 Seville, Spain., Reguera-Ortega JL; Department of Haematology, University Hospital Virgen del Rocío, Instituto de Biomedicina de Sevilla (IBIS)/CSIC, University of Seville, 41012 Seville, Spain., Abdel-Kader Martín L; Department of Pharmacy, University Hospital Virgen del Rocío, 41013 Seville, Spain.; Department of Pharmacy and Pharmaceutical Technology, University of Seville, 41012 Seville, Spain., Flores-Moreno S; Department of Pharmacy, University Hospital Virgen del Rocío, 41013 Seville, Spain.

المصدر: International journal of molecular sciences [Int J Mol Sci] 2023 Sep 30; Vol. 24 (19). Date of Electronic Publication: 2023 Sep 30.

نوع المنشور: Systematic Review; Journal Article; Review

بيانات الدورية: Publisher: MDPI Country of Publication: Switzerland NLM ID: 101092791 Publication Model: Electronic Cited Medium: Internet ISSN: 1422-0067 (Electronic) Linking ISSN: 14220067 NLM ISO Abbreviation: Int J Mol Sci Subsets: MEDLINE

مواضيع طبية MeSH: Receptors, Chimeric Antigen* , Hematologic Neoplasms*/therapy, Humans ; Immune Checkpoint Inhibitors/pharmacology ; Immune Checkpoint Inhibitors/therapeutic use ; Programmed Cell Death 1 Receptor ; Neoplasm Recurrence, Local ; Immunotherapy, Adoptive/methods ; T-Lymphocytes

المؤلفون: García-Calderón CB; Servicio de Hematología, Hospital Universitario Virgen del Rocío, Instituto de Biomedicina de Sevilla, (IBIS/CSIC), Universidad de Sevilla, Sevilla, Spain., Sierro-Martínez B; Servicio de Hematología, Hospital Universitario Virgen del Rocío, Instituto de Biomedicina de Sevilla, (IBIS/CSIC), Universidad de Sevilla, Sevilla, Spain., García-Guerrero E; Servicio de Hematología, Hospital Universitario Virgen del Rocío, Instituto de Biomedicina de Sevilla, (IBIS/CSIC), Universidad de Sevilla, Sevilla, Spain., Sanoja-Flores L; Servicio de Hematología, Hospital Universitario Virgen del Rocío, Instituto de Biomedicina de Sevilla, (IBIS/CSIC), Universidad de Sevilla, Sevilla, Spain., Muñoz-García R; Servicio de Inmunología, Instituto de Biomedicina de Sevilla (IBiS), Hospital Universitario Virgen del Rocío, Centro Superior de Investigaciones Científicas (CSIC), Universidad de Sevilla, Sevilla, Spain., Ruiz-Maldonado V; Servicio de Hematología, Hospital Universitario Virgen del Rocío, Instituto de Biomedicina de Sevilla, (IBIS/CSIC), Universidad de Sevilla, Sevilla, Spain., Jimenez-Leon MR; Servicio de Hematología, Hospital Universitario Virgen del Rocío, Instituto de Biomedicina de Sevilla, (IBIS/CSIC), Universidad de Sevilla, Sevilla, Spain., Delgado-Serrano J; Servicio de Hematología, Hospital Universitario Virgen del Rocío, Instituto de Biomedicina de Sevilla, (IBIS/CSIC), Universidad de Sevilla, Sevilla, Spain., Molinos-Quintana Á; Servicio de Hematología, Hospital Universitario Virgen del Rocío, Instituto de Biomedicina de Sevilla, (IBIS/CSIC), Universidad de Sevilla, Sevilla, Spain., Guijarro-Albaladejo B; Servicio de Hematología, Hospital Universitario Virgen del Rocío, Instituto de Biomedicina de Sevilla, (IBIS/CSIC), Universidad de Sevilla, Sevilla, Spain., Carrasco-Brocal I; Servicio de Hematología, Hospital Universitario Virgen del Rocío, Instituto de Biomedicina de Sevilla, (IBIS/CSIC), Universidad de Sevilla, Sevilla, Spain., Lucena JM; Servicio de Inmunología, Instituto de Biomedicina de Sevilla (IBiS), Hospital Universitario Virgen del Rocío, Centro Superior de Investigaciones Científicas (CSIC), Universidad de Sevilla, Sevilla, Spain., García-Lozano JR; Servicio de Inmunología, Instituto de Biomedicina de Sevilla (IBiS), Hospital Universitario Virgen del Rocío, Centro Superior de Investigaciones Científicas (CSIC), Universidad de Sevilla, Sevilla, Spain., Blázquez-Goñi C; Servicio de Hematología, Hospital Universitario Virgen del Rocío, Instituto de Biomedicina de Sevilla, (IBIS/CSIC), Universidad de Sevilla, Sevilla, Spain., Reguera-Ortega JL; Servicio de Hematología, Hospital Universitario Virgen del Rocío, Instituto de Biomedicina de Sevilla, (IBIS/CSIC), Universidad de Sevilla, Sevilla, Spain., González-Escribano MF; Servicio de Inmunología, Instituto de Biomedicina de Sevilla (IBiS), Hospital Universitario Virgen del Rocío, Centro Superior de Investigaciones Científicas (CSIC), Universidad de Sevilla, Sevilla, Spain., Reinoso-Segura M; Servicio de Hematología, Hospital Universitario Virgen del Rocío, Instituto de Biomedicina de Sevilla, (IBIS/CSIC), Universidad de Sevilla, Sevilla, Spain., Briones J; Hematology Service, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain., Pérez-Simón JA; Servicio de Hematología, Hospital Universitario Virgen del Rocío, Instituto de Biomedicina de Sevilla, (IBIS/CSIC), Universidad de Sevilla, Sevilla, Spain., Caballero-Velázquez T; Servicio de Hematología, Hospital Universitario Virgen del Rocío, Instituto de Biomedicina de Sevilla, (IBIS/CSIC), Universidad de Sevilla, Sevilla, Spain.

المصدر: Frontiers in immunology [Front Immunol] 2023 Apr 14; Vol. 14, pp. 1152498. Date of Electronic Publication: 2023 Apr 14 (Print Publication: 2023).

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE

مواضيع طبية MeSH: Receptors, Chimeric Antigen*/genetics , Lymphoma, Large B-Cell, Diffuse*/pathology, Humans ; Kinetics ; B-Lymphocytes/pathology ; T-Lymphocytes/pathology

المؤلفون: Iacoboni G; Department of Hematology, Vall d'Hebron University Hospital, Experimental Hematology, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.; Department of Medicine, Universitat Autònoma de Barcelona, Bellaterra, Spain., Rejeski K; Department of Medicine III, University Hospital, LMU Munich, Munich, Germany., Villacampa G; Oncology Data Science, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.; SOLTI Breast Cancer Research Group, Barcelona, Spain.; The Institute of Cancer Research, London, United Kingdom., van Doesum JA; Department of Hematology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands., Chiappella A; Division of Hematology and Stem Cell Transplantation, Fondazione IRCCS Istituto Nazionale dei Tumori, University of Milano, Milano, Italy., Bonifazi F; IRCCS Azienda Ospedaliero-Universitaria di Bologna Istituto di Ematologia 'Seràgnoli', Bologna, Italy., Lopez-Corral L; Hematology Department, Hospital Clínico Universitario de Salamanca, IBSAL, CIBERONC, Salamanca, Spain.; Centro de Investigación del Cáncer-IBMCC, Salamanca, Spain., van Aalderen M; Department of Hematology, Amsterdam University Medical Centers, Cancer Center Amsterdam, LYMMCARE (Lymphoma and Myeloma Center Amsterdam), Amsterdam, The Netherlands., Kwon M; Department of Hematology, Hospital General Universitario Gregorio Marañón, Madrid, Spain.; Gregorio Marañón Health Research Institute, Madrid, Spain., Martínez-Cibrian N; Department of Hematology, Hospital Clinic, Barcelona, Spain., Bramanti S; Istituto Clinico Humanitas IRCCS, Rozzano, Italy., Reguera-Ortega JL; Department of Hematology, University Hospital Virgen del Rocio, Sevilla, Spain., Camacho-Arteaga L; Clinical Pharmacology Department, Vall d'Hebron University Hospital, Barcelona, Spain.; Clinical Pharmacology, Vall d'Hebron Institut de Recerca, Vall d'Hebron Hospital Universitari, Barcelona, Spain.; Department of Pharmacology, Therapeutics and Toxicology, Autonomous University of Barcelona, Barcelona, Spain; and., Schmidt C; Department of Medicine III, University Hospital, LMU Munich, Munich, Germany., Marín-Niebla A; Department of Hematology, Vall d'Hebron University Hospital, Experimental Hematology, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.; Department of Medicine, Universitat Autònoma de Barcelona, Bellaterra, Spain., Kersten MJ; Department of Hematology, Amsterdam University Medical Centers, Cancer Center Amsterdam, LYMMCARE (Lymphoma and Myeloma Center Amsterdam), Amsterdam, The Netherlands., Martin Garcia-Sancho A; Hematology Department, Hospital Clínico Universitario de Salamanca, IBSAL, CIBERONC, Salamanca, Spain., Zinzani PL; IRCCS Azienda Ospedaliero-Universitaria di Bologna Istituto di Ematologia 'Seràgnoli', Bologna, Italy.; Dipartimento di Medicina Specialistica, Diagnostica e Sperimentale Università di Bologna, Bologna, Italy., Corradini P; Division of Hematology and Stem Cell Transplantation, Fondazione IRCCS Istituto Nazionale dei Tumori, University of Milano, Milano, Italy., van Meerten T; Department of Hematology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands., Subklewe M; Department of Medicine III, University Hospital, LMU Munich, Munich, Germany., Barba P; Department of Hematology, Vall d'Hebron University Hospital, Experimental Hematology, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.; Department of Medicine, Universitat Autònoma de Barcelona, Bellaterra, Spain.

المصدر: Blood advances [Blood Adv] 2022 Jun 28; Vol. 6 (12), pp. 3606-3610.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: American Society of Hematology Country of Publication: United States NLM ID: 101698425 Publication Model: Print Cited Medium: Internet ISSN: 2473-9537 (Electronic) Linking ISSN: 24739529 NLM ISO Abbreviation: Blood Adv Subsets: MEDLINE

مواضيع طبية MeSH: Antineoplastic Agents*/therapeutic use , Lymphoma, Mantle-Cell*/drug therapy , Lymphoma, Mantle-Cell*/pathology, Adult ; Humans ; Immunotherapy, Adoptive ; Neoplasm Recurrence, Local/drug therapy ; Pyrimidines/therapeutic use ; Receptors, Chimeric Antigen

المؤلفون: Rodríguez-Gil A; Instituto de Biomedicina de Sevilla (IBiS/CSIC/Universidad de Sevilla), Seville, Spain. arg@us.es.; Centro de Investigación Biomédica en Red en Cáncer-CIBERONC, Madrid, Spain. arg@us.es.; Hospital Universitario Virgen del Rocío (HUVR), Seville, Spain. arg@us.es.; Departamento de Fisiología Médica y Biofísica, Universidad de Sevilla, Seville, Spain. arg@us.es.; Instituto de Biomedicina de Sevilla (IBiS / CSIC) - CIBERONC and Departamento de Fisiología Médica y Biofísica, Universidad de Sevilla, Avda. Manuel Siurot s/n, 41013, Seville, Spain. arg@us.es., Escamilla-Gómez V; Instituto de Biomedicina de Sevilla (IBiS/CSIC/Universidad de Sevilla), Seville, Spain.; Centro de Investigación Biomédica en Red en Cáncer-CIBERONC, Madrid, Spain.; Hospital Universitario Virgen del Rocío (HUVR), Seville, Spain., Nufer M; Instituto de Biomedicina de Sevilla (IBiS/CSIC/Universidad de Sevilla), Seville, Spain., Andújar-Sánchez F; Instituto de Biomedicina de Sevilla (IBiS/CSIC/Universidad de Sevilla), Seville, Spain., Lopes-Ramos T; Instituto de Biomedicina de Sevilla (IBiS/CSIC/Universidad de Sevilla), Seville, Spain.; Centro de Investigación Biomédica en Red en Cáncer-CIBERONC, Madrid, Spain.; Division of Blood and Marrow Transplantation, Stanford University, Stanford, CA, USA., Bejarano-García JA; Instituto de Biomedicina de Sevilla (IBiS/CSIC/Universidad de Sevilla), Seville, Spain., García-Guerrero E; Instituto de Biomedicina de Sevilla (IBiS/CSIC/Universidad de Sevilla), Seville, Spain.; Centro de Investigación Biomédica en Red en Cáncer-CIBERONC, Madrid, Spain.; Hospital Universitario Virgen del Rocío (HUVR), Seville, Spain., Calderón-Cabrera C; Instituto de Biomedicina de Sevilla (IBiS/CSIC/Universidad de Sevilla), Seville, Spain.; Centro de Investigación Biomédica en Red en Cáncer-CIBERONC, Madrid, Spain.; Hospital Universitario Virgen del Rocío (HUVR), Seville, Spain., Caballero-Velázquez T; Instituto de Biomedicina de Sevilla (IBiS/CSIC/Universidad de Sevilla), Seville, Spain.; Centro de Investigación Biomédica en Red en Cáncer-CIBERONC, Madrid, Spain.; Hospital Universitario Virgen del Rocío (HUVR), Seville, Spain.; Departamento de Medicina, Universidad de Sevilla, Seville, Spain., García-Calderón CB; Instituto de Biomedicina de Sevilla (IBiS/CSIC/Universidad de Sevilla), Seville, Spain.; Hospital Universitario Virgen del Rocío (HUVR), Seville, Spain., Hernández-Díaz P; Instituto de Biomedicina de Sevilla (IBiS/CSIC/Universidad de Sevilla), Seville, Spain.; Hospital Universitario Virgen del Rocío (HUVR), Seville, Spain., Reguera-Ortega JL; Hospital Universitario Virgen del Rocío (HUVR), Seville, Spain., Rodríguez-Torres N; Hospital Universitario Virgen del Rocío (HUVR), Seville, Spain., Martínez-Cibrián N; Hospital Universitario Virgen del Rocío (HUVR), Seville, Spain., Rodríguez-Barbosa JI; Instituto de Biología Molecular, Área de Inmunología, Universidad de León, León, Spain., Villadiego J; Instituto de Biomedicina de Sevilla (IBiS/CSIC/Universidad de Sevilla), Seville, Spain.; Departamento de Fisiología Médica y Biofísica, Universidad de Sevilla, Seville, Spain.; Centro de Investigación Biomédica en Red Sobre Enfermedades Neurodegenerativas-CIBERNED, Madrid, Spain., Pérez-Simón JA; Instituto de Biomedicina de Sevilla (IBiS/CSIC/Universidad de Sevilla), Seville, Spain.; Centro de Investigación Biomédica en Red en Cáncer-CIBERONC, Madrid, Spain.; Hospital Universitario Virgen del Rocío (HUVR), Seville, Spain.; Departamento de Medicina, Universidad de Sevilla, Seville, Spain.

المصدر: Scientific reports [Sci Rep] 2022 May 19; Vol. 12 (1), pp. 8348. Date of Electronic Publication: 2022 May 19.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited Medium: Internet ISSN: 2045-2322 (Electronic) Linking ISSN: 20452322 NLM ISO Abbreviation: Sci Rep Subsets: MEDLINE

مواضيع طبية MeSH: Graft vs Host Disease*/drug therapy, Animals ; Disease Models, Animal ; Mice ; Nitriles ; Pyrazoles ; Pyrimidines ; T-Lymphocytes, Regulatory/transplantation

المؤلفون: Iacoboni G; Department of Hematology, University Hospital Vall d'Hebron, Barcelona, Spain.; Department of Medicine, Universitat Autònoma de Barcelona, Bellaterra, Spain.; Experimental Hematology, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain., Villacampa G; Oncology Data Science, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain., Martinez-Cibrian N; Department of Hematology, University Hospital Virgen del Rocio, Sevilla, Spain., Bailén R; Department of Hematology, Hospital General Universitario Gregorio Marañón, Madrid, Spain.; Gregorio Marañón Health Research Institute (IiSGM), Madrid, Spain., Lopez Corral L; Hematology Department, Hospital Clínico Universitario de Salamanca, IBSAL, CIBERONC, Salamanca, Spain.; Centro de Investigación del Cáncer-IBMCC, Salamanca, Spain., Sanchez JM; Hematology Department, Hospital 12 de Octubre, Madrid, Spain., Guerreiro M; Department of Hematology, Hospital La Fe, Valencia, Spain., Caballero AC; Hematology Department, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain.; Josep Carreras Leukaemia Research Institute, Barcelona, Spain., Mussetti A; Hematology Department, Institut Catala d'Oncologia, Hospital Duran i Reynals, L'Hospitalet De Llobregat, Spain.; Institut d'Investigació Biomèdica de Bellvitge (IDIBELL), L'Hospitalet De Llobregat, Barcelona, Spain., Sancho JM; Hematology Department, ICO-IJC Hospital Germans Trias i Pujol, Barcelona, Spain., Hernani R; Department of Hematology, Hospital Clínico Universitario de Valencia, Valencia, Spain.; Instituto de Investigación Sanitaria INCLIVA, Valencia, Spain., Abrisqueta P; Department of Hematology, University Hospital Vall d'Hebron, Barcelona, Spain.; Department of Medicine, Universitat Autònoma de Barcelona, Bellaterra, Spain.; Experimental Hematology, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain., Solano C; Department of Hematology, Hospital Clínico Universitario de Valencia, Valencia, Spain.; Instituto de Investigación Sanitaria INCLIVA, Valencia, Spain.; Department of Medicine, University of Valencia, Valencia, Spain., Sureda A; Hematology Department, Institut Catala d'Oncologia, Hospital Duran i Reynals, L'Hospitalet De Llobregat, Spain.; Institut d'Investigació Biomèdica de Bellvitge (IDIBELL), L'Hospitalet De Llobregat, Barcelona, Spain., Briones J; Hematology Department, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain.; Josep Carreras Leukaemia Research Institute, Barcelona, Spain., Martin Garcia-Sancho A; Hematology Department, Hospital Clínico Universitario de Salamanca, IBSAL, CIBERONC, Salamanca, Spain.; Centro de Investigación del Cáncer-IBMCC, Salamanca, Spain., Kwon M; Department of Hematology, Hospital General Universitario Gregorio Marañón, Madrid, Spain.; Gregorio Marañón Health Research Institute (IiSGM), Madrid, Spain., Reguera-Ortega JL; Department of Hematology, University Hospital Virgen del Rocio, Sevilla, Spain., Barba P; Department of Hematology, University Hospital Vall d'Hebron, Barcelona, Spain.; Department of Medicine, Universitat Autònoma de Barcelona, Bellaterra, Spain.; Experimental Hematology, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.

مؤلفون مشاركون: GETH, GELTAMO Spanish Groups

المصدر: Cancer medicine [Cancer Med] 2021 May; Vol. 10 (10), pp. 3214-3223. Date of Electronic Publication: 2021 May 01.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: John Wiley & Sons Ltd Country of Publication: United States NLM ID: 101595310 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2045-7634 (Electronic) Linking ISSN: 20457634 NLM ISO Abbreviation: Cancer Med Subsets: MEDLINE

مواضيع طبية MeSH: Lymphoma, Large B-Cell, Diffuse/*drug therapy , Neoplasm Recurrence, Local/*drug therapy , Receptors, Antigen, T-Cell/*therapeutic use, Aged ; Cytokines/metabolism ; Female ; Humans ; Leukapheresis/methods ; Lymphoma, Large B-Cell, Diffuse/metabolism ; Male ; Middle Aged ; Neoplasm Recurrence, Local/metabolism ; Progression-Free Survival ; Receptors, Chimeric Antigen/metabolism ; Retrospective Studies ; Standard of Care